Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal Membrane
Status:
Terminated
Trial end date:
2017-09-14
Target enrollment:
Participant gender:
Summary
This study seeks to evaluate the effect of the intravitreal 0.7mg dexamethasone implant on
central macular thickness and visual acuity in those patients with persistent macular edema
after pars plana vitrectomy for epiretinal membrane.